BioSpace News Archive

Business

MoonLake Immunotherapeutics appoints former Kymab CEO Simon Sturge as Chairman and Spike Loy to the Board of Directors

MoonLake Immunotherapeutics AG today announced the appointment of Mr. Sturge as Chairman.

August 10, 2021
·
3 min read
Business

iSpecimen Reports Second Quarter 2021 Financial Results

iSpecimen Inc. today reported its financial results for the three-month period ended June 30, 2021.

August 10, 2021
·
12 min read
Business

Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results

Anticipate initiating a Phase 3 trial of adjunctive ganaxolone in tuberous sclerosis complex (TSC) in Q3 2021, targeting first patient enrolled during Q4 2021; continue to expect topline Phase 2, open label data in Q3 2021

August 10, 2021
·
15 min read
Deals

Visus Therapeutics Secures $20 Million in Additional Financing Led by New Investor LSP, with Participation from Sage Partners

Proceeds will support clinical and commercial efforts for lead asset BRIMOCHOL™ under investigation for presbyopia as well as new research and development activities in the Company’s drug development pipeline

August 10, 2021
·
4 min read
Deals

Nanox Enters into Acquisition via Merger Agreement with Zebra Medical Vision Ltd. and Announces Entry into Binding Letter of Intent with USARAD Holdings Inc.

Upon the consummation of the acquisition, Nanox and Zebra Medical Vision anticipate that their mutual goal of global scanning to protect one’s health will put them in the position to potentially become the next generation AI-enabled medical device leader.

August 10, 2021
·
13 min read
Biotech Beach

Aurora Spine Corporation Announces First Patients in Multicenter Study of ZIP® Interspinous Fixation Device

Aurora Spine Corporation today announced that the first patients have been enrolled into a pivotal multi-center study of its ZIP® Interspinous Fixation device for patients suffering from back pain due to symptomatic degenerative disc disease.

August 10, 2021
·
4 min read
Drug Development

IMV Announces Final Topline Results of the DeCidE1 Clinical Trial in Advanced Recurrent Ovarian Cancer

IMV Inc. today announced the final topline results of the DeCidE1 Phase 2 clinical trial evaluating maveropepimut-S (MVP-S, formerly known as DPX-Survivac) in subjects with advanced recurrent ovarian cancer.

August 10, 2021
·
5 min read
Biotech Beach

BioLargo Q2 2021 Earnings Results Webcast and Conference Call Wednesday, August 17, 2021 - 11:00 AM Eastern Time

BioLargo, Inc. will host an investor webcast and conference call on Wednesday August 17, 2021, at 8:00 am PST / 11:00 am EST, open to the public, to review the company’s financial results, discuss recent events, and conduct a question-and-answer session.

August 10, 2021
·
2 min read
Immunovia Provides Updates on the Price for the IMMrayTM PanCan-d Test in the US and Improved Test Performance in the Familial/Hereditary Risk Group

Immunovia AB received final regulatory approval to begin patient testing with the IMMray TM PanCan-d test, the first and only test on the market dedicated to the early detection of pancreatic cancer.

August 10, 2021
·
4 min read
Business

Acerus Reports Fiscal 2021 Second Quarter Financial ResultsRevenue Triples after Buyback of US Rights for NATESTO®

Acerus Pharmaceuticals Corporation today reported its financial results for the three and six-month period ended June 30, 2021.

August 10, 2021
·
14 min read